• |
  • |
  • |
  • |
Donate

Product

Journal: An Update on Psychopharmacological Treatment of Autism Spectrum Disorder

Center:
Fiscal Year:
2024
Contact Information:
Product Description:
We provide a review of current psychopharmacological treatment in ASD including those used to address common comorbidities of the condition and upcoming new targeted approaches in autism management. Medications including metformin, arbaclofen, cannabidiol, oxytocin, bumetanide, lovastatin, trofinetide, and dietary supplements including sulforophane and N-acetylcysteine are discussed.
Keyword(s):
Autism, Psychopharmacological treatment
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals Published/In Press
Target Audience:
Professionals
Alternative Format:
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A